State of Tennessee, Department of Treasury’s Tvardi Therapeutics TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-426
Closed -$43.4K 1745
2023
Q2
$43.4K Hold
426
﹤0.01% 1700
2023
Q1
$75.3K Sell
426
-26
-6% -$8.71K ﹤0.01% 1633
2022
Q4
$175K Hold
452
﹤0.01% 1549
2022
Q3
$152K Buy
452
+21
+5% +$7.61K ﹤0.01% 1564
2022
Q2
$142K Hold
431
﹤0.01% 1582
2022
Q1
$188K Sell
431
-344
-44% -$141K ﹤0.01% 1597
2021
Q4
$339K Buy
775
+223
+40% +$112K ﹤0.01% 1474
2021
Q3
$308K Sell
552
-356
-39% -$179K ﹤0.01% 1503
2021
Q2
$467K Buy
+908
New +$575K ﹤0.01% 1392

Other funds holding TVRD

State of Tennessee, Department of Treasury's TVRD Position: Q3 2023 in Review

State of Tennessee, Department of Treasury sold out of Tvardi Therapeutics (TVRD) in Q3 2023, closing a stake of 426 shares — an estimated $43.4K sold.

State of Tennessee, Department of Treasury first reported a position in TVRD in Q2 2021 and held it in 9 quarters. The position peaked at $467K in Q2 2021. 122 funds tracked by Wall St. Rank hold TVRD as of Q3 2023.

  • State of Tennessee, Department of Treasury reported no remaining Tvardi Therapeutics position as of Q3 2023 after selling out during the quarter.
  • State of Tennessee, Department of Treasury sold 426 Tvardi Therapeutics shares in Q3 2023, an estimated $43.4K.
  • State of Tennessee, Department of Treasury first reported a position in Tvardi Therapeutics in Q2 2021 and held it in 9 quarters.
  • State of Tennessee, Department of Treasury's Tvardi Therapeutics position peaked at $467K in Q2 2021.
  • 122 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q3 2023.

Based on State of Tennessee, Department of Treasury's 13F filing for Q3 2023, filed 14 Nov 2023.